SCOPUS 정보 검색 플랫폼

Pharmaceutical Research

Volumn 18, Issue 6, 2001, Pages 734-741

Novel direct curve comparison metrics for bioequivalence

(2) Polli, James E a McLean, Angus M b

a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY (United States)

b Shire Laboratories Inc (United States)

Author keywords

Bioavailability; Bioequivalence; Carbamazepine

Indexed keywords

CARBAMAZEPINE;

AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; CALCULATION; DRUG DISTRIBUTION; DRUG FORMULATION; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANTICONVULSANTS; AREA UNDER CURVE; CARBAMAZEPINE; CONFIDENCE INTERVALS; DELAYED-ACTION PREPARATIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; THERAPEUTIC EQUIVALENCY;

EID: 0034858882 PISSN: 07248741 EISSN: None Source Type: Journal
DOI: 10.1023/A:1011067908500 Document Type: Article

Times cited : (24)

References (27)

1
- 0026772726
- Bioequivalence
- (1992) Pharm. Res. , vol.9 , pp. 925-928
- Rescigno, A.¹

2
- 0030958197
- The multivariate assessment of bioequivalence
- (1997) J. Biopharm. Stat. , vol.7 , pp. 113-123
- Chincilli, V.M.¹ Elswick, R.K.²

3
- 0030772854
- Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence
- (1997) Pharm. Res. , vol.14 , pp. 1363-1369
- Marston, S.A.¹ Polli, J.E.²

4
- 0003547433
- FDA Center for Drug Evaluation and Research, Rockville, MD
- (1997) Approved Drug Products with Therapeutic Equivalence Evaluations, 17th edition

5
- 84955525983
- (1977) Federal Register , vol.42 , pp. 1648

6
- 0028223647
- Bioequivalence: Performance of several measures of extent of absorption
- (1994) Pharm. Res. , vol.11 , pp. 715-722
- Bois, F.Y.¹ Tozer, T.N.² Hauck, W.W.³ Chen, M.L.⁴ Patnaik, R.⁵ Williams, R.L.⁶

7
- 0030060434
- Tmax: An unconfounded metric for rate of absorption in single dose bioquivalence studies
- (1996) Pharm. Res. , vol.13 , pp. 324-328
- Basson, R.P.¹ Cerimel, B.J.² DeSante, K.A.³ Howey, D.C.⁴

8
- 0027987256
- Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies - "Moving the goalposts" or changing the "game"
- (1994) J. Pharm. Sci. , vol.83 , pp. 1554-1557
- Rostami-Hodjegan, A.¹ Jackson, P.R.² Tucker, G.T.³

9
- 0003947343
- Health Protection Branch
- (1992) Report from Expert Advisory Committee on Biovailability Guidelines and Standards for Bioavailability. Part A. Oral Dosage Forms Used for Systemic Effects

10
- 0026602605
- Comparison of absorption rates in bioquivalence studies of immediate release drug formulations
- (1992) Int. J. Clin. Ther. Toxicol. , vol.30 , pp. 153-159
- Schall, R.¹ Luus, H.G.²

11
- 0028285930
- Evaluation of different measures of rate of drug absorption in comparative pharmacokinetic studies
- (1994) J. Pharm. Sci. , vol.83 , pp. 212-215
- Lacey, L.F.¹ Keene, O.N.² Duquesnoy, C.³ Bye, A.⁴

12
- 0028989927
- Without extrapolation, Cmax/AUC is an effective metric in investigations of bioequivalence
- (1995) Pharm. Res. , vol.12 , pp. 937-942
- Tothfalusi, L.¹ Endrenyi, L.²

13
- 0029940802
- Absorption rate vs. exposure: Which is more useful for bioequivalence testing?
- (1996) Pharm. Res. , vol.13 , pp. 453-456
- Tozer, T.N.¹ Bois, F.Y.² Hauck, W.W.³ Chen, M.L.⁴ Williams, R.L.⁵

14
- 0032959542
- Bioavailability of carbamazepine from four different products and the occurrence of side effects
- (1999) Biopharm. Drug Dispos. , vol.20 , pp. 19-28
- Olling, M.¹ Mensinga, T.T.² Barends, D.M.³ Groen, C.⁴ Lake, O.A.⁵ Meulenbet, J.⁶

15
- 0026488257
- An alternative approach for assessment of rate of absorption in bioequivalence studies
- (1992) Pharm. Res. , vol.9 , pp. 1380-1385
- Chen, M.L.¹

16
- 0031917671
- Why rate of absorption inferences in single dose bioequivalence studies are often inappropriate
- (1998) Pharm. Res. , vol.15 , pp. 276-279
- Basson, R.P.¹ Ghosh, A.² Cerimele, B.J.³ DeSante, K.A.⁴ Howey, D.C.⁵

17
- 0031689198
- Metrics comparing simulated early concentration profiles for the determination of bioequivalence
- (1998) Pharm. Res. , vol.15 , pp. 1292-1299
- Endrenyi, L.¹ Csizmadia, F.² Tothfalusi, L.³ Chen, M.L.⁴

18
- 0031093591
- Secondary metrics for the assessment of bioequivalence
- (1997) J. Pharm. Sci. , vol.86 , pp. 401-402
- Endrenyi, L.¹ Tothalusi, L.²

19
- 0003949750
- Response to "Is Cmax/AUC useful for bioequivalence testing?"
- (1997) J. Pharm. Sci. , vol.86 , pp. 1505-1506
- Endrenyi, L.¹ Tothalusi, L.²

20
- 0031307930
- Is Cmax/AUC useful for bioequivalence testing?
- (1997) J. Pharm. Sci. , vol.86 , pp. 1504-1505
- Rostami-Hodjega, A.¹ Tucher, G.T.²

21
- 0030611077
- Cmax/AUC, a commentary
- (1997) Pharm. Res. , vol.14 , pp. 967-968
- Tozer, T.N.¹ Hauck, W.W.²

22
- 0029940802
- Absorption rate vs. exposure: Which is more useful for bioequivalence testing?
- (1996) Pharm. Res. , vol.13 , pp. 453-456
- Tozer, T.N.¹ Bois, F.Y.² Hauck, W.W.³ Chen, M.L.⁴ Williams, R.L.⁵

23
- 0031936095
- Pharmacokinetic evaluation of a twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy
- (1998) Epilepsia , vol.39 , pp. 274-279
- Garnett, W.R.¹ Levy, B.² McLean, A.M.³ Zhang, Y.⁴ Couch, R.A.⁵ Rudnic, E.M.⁶ Pellock, J.M.⁷ Belendiuk, G.W.⁸

24
- 0004324584
- FDA, Rockville, MD
- (1992) Statistical Procedures for Bioequivalence Studies Using a Standard Two-treatment Crossover Design. Center for Drug Evaluation and Research

25
- 0030926727
- Methods to compare dissoution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets
- (1997) J. Pharm. Sci. , vol.86 , pp. 690-700
- Polli, J.E.¹ Rekhi, G.S.² Augsburger, L.L.³ Shah, V.P.⁴

26
- 0003633894
- The Iowa State University Press, Ames, IA
- (1980) Statistical Methods
- Snedecor, G.W.¹ Cochran, W.G.²

27
- 0003804331
- Prentice Hall, Upper Saddle River, NJ
- (1996) Desktop Data Analysis with SYSTAT
- Wilkinson, L.¹ Blank, G.² Gruber, C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.